Monday, October 19, 2026

USD/CHF Is 1% Up In The Last 10 Sessions

ViaNews Editorial Team

September 12, 2024

USD/CHF Is 1% Up In The Last 10 Sessions

(VIANEWS) - USD/CHF (USDCHF) has been up by 1.31% for the last 10 sessions. At 20:08 EST on Wednesday, 11 September, USD/CHF (USDCHF) is $0.85.

USD/CHF's yearly highs and lows, it's 2.377% up from its 52-week low and 7.736% down from its 52-week high.

Volatility

USD/CHF's last week, last month's, and last quarter's current intraday variation average was a negative 0.07%, a negative 0.10%, and a positive 0.36%, respectively.

USD/CHF's highest amplitude of average volatility was 0.32% (last week), 0.36% (last month), and 0.36% (last quarter), respectively.

News about

  • Usd/jpy: break below double-bottom May open room for further downside – OCBC. According to FXStreet on Wednesday, 11 September, "We reiterate that FedBoJ policy shifts and growing pace of normalisation can bring about faster narrowing of UST-JGB yield differentials and this should continue to underpin the broader direction of travel for USD/JPY to the downside. ", "The drop in USD/JPY may also have triggered stop-sell orders, resulting in the fairly sharp move to trade below 141.50 low. "
  • Usd/jpy steadily climbs back closer to mid-143.00s, upside potential seems limited. According to FXStreet on Tuesday, 10 September, "Apart from this, a generally positive risk tone around the equity markets dents demand for the safe-haven JPY and acts as a tailwind for the USD/JPY pair amid some follow-through US Dollar (USD) buying interest.", "This might hold back bullish traders from placing aggressive bets around the USD/JPY pair and cap gains."
  • According to FXStreet on Wednesday, 11 September, "The US Dollar has come under fresh selling pressure against its major currency rivals, mainly driven by the USD/JPY slide following BoJ Nagakawa's comments. "
  • Usd/jpy drops to near 141.00 following the remarks from boj’s junko nagakawa. According to FXStreet on Wednesday, 11 September, "The downside of the USD/JPY pair is also driven by the contrasting monetary policies of the Bank of Japan and the US Federal Reserve, which has been encouraging the unwinding of carry trades and boosting demand for the Japanese. "
  • Usd/jpy price forecast: sticks to modest gains near mid-143.00s, not out of the woods yet. According to FXStreet on Tuesday, 10 September, "In the meantime, a downward revision of the second quarter Gross Domestic Product (GDP) print continues to undermine the Japanese Yen (JPY) and acts as a tailwind for the USD/JPY pair amid a modest US Dollar (USD) uptick. ", "The USD/JPY pair attracts some buyers for the second straight day on Tuesday and trades around mid-143.00s during the first half of the European session. "

More news about USD/CHF (USDCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,396 source documents archived
Query this data → isubstrate.com